
### [MONDO:0018787](http://purl.obolibrary.org/obo/MONDO_0018787)
**Label:** genetic cerebral small vessel disease

**Subclasses:** [MONDO:0018789](http://purl.obolibrary.org/obo/MONDO_0018789) (COL4A1 or COL4A2-related cerebral small vessel disease with ischemic tendancy), [MONDO:0013773](http://purl.obolibrary.org/obo/MONDO_0013773) (porencephaly 2), [MONDO:0018788](http://purl.obolibrary.org/obo/MONDO_0018788) (COL4A1 or COL4A2-related cerebral small vessel disease), [MONDO:0015033](http://purl.obolibrary.org/obo/MONDO_0015033) (ABeta amyloidosis, dutch type), [MONDO:0018786](http://purl.obolibrary.org/obo/MONDO_0018786) (pontine autosomal dominant microangiopathy with leukoencephalopathy), [MONDO:0008289](http://purl.obolibrary.org/obo/MONDO_0008289) (porencephaly 1), [MONDO:0008641](http://purl.obolibrary.org/obo/MONDO_0008641) (retinal vasculopathy and cerebral leukoencephalopathy), [MONDO:0008306](http://purl.obolibrary.org/obo/MONDO_0008306) (ABri amyloidosis), [MONDO:0005620](http://purl.obolibrary.org/obo/MONDO_0005620) (cerebral amyloid angiopathy), [MONDO:0010829](http://purl.obolibrary.org/obo/MONDO_0010829) (CARASIL), [MONDO:0018829](http://purl.obolibrary.org/obo/MONDO_0018829) (familial schizencephaly), [MONDO:0012726](http://purl.obolibrary.org/obo/MONDO_0012726) (autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome), [MONDO:0014768](http://purl.obolibrary.org/obo/MONDO_0014768) (CADASIL 2), [MONDO:0015026](http://purl.obolibrary.org/obo/MONDO_0015026) (cerebroretinal microangiopathy with calcifications and cysts 2;), [MONDO:0018831](http://purl.obolibrary.org/obo/MONDO_0018831) (HTRA1-related cerebral small vessel disease), [MONDO:0018832](http://purl.obolibrary.org/obo/MONDO_0018832) (HTRA1-related autosomal dominant cerebral small vessel disease), [MONDO:0008373](http://purl.obolibrary.org/obo/MONDO_0008373) (retinal arterial tortuosity (disease)), [MONDO:0011583](http://purl.obolibrary.org/obo/MONDO_0011583) (cerebral amyloid angiopathy, App-related), [MONDO:0020496](http://purl.obolibrary.org/obo/MONDO_0020496) (familial porencephaly), [MONDO:0018790](http://purl.obolibrary.org/obo/MONDO_0018790) (COL4A1 or COL4A2-related cerebral small vessel disease with hemorrhagic tendancy), [MONDO:0012815](http://purl.obolibrary.org/obo/MONDO_0012815) (Coats plus syndrome), [MONDO:0007432](http://purl.obolibrary.org/obo/MONDO_0007432) (CADASIL), [MONDO:0007297](http://purl.obolibrary.org/obo/MONDO_0007297) (ADan amyloidosis), [MONDO:0007098](http://purl.obolibrary.org/obo/MONDO_0007098) (ACys amyloidosis), [MONDO:0017948](http://purl.obolibrary.org/obo/MONDO_0017948) (ABetaA21G amyloidosis), [MONDO:0017949](http://purl.obolibrary.org/obo/MONDO_0017949) (ABeta amyloidosis, Arctic type), [MONDO:0017946](http://purl.obolibrary.org/obo/MONDO_0017946) (ABeta amyloidosis, Iowa type), [MONDO:0017947](http://purl.obolibrary.org/obo/MONDO_0017947) (ABeta amyloidosis, Italian type), [MONDO:0017804](http://purl.obolibrary.org/obo/MONDO_0017804) (autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome), [MONDO:0017945](http://purl.obolibrary.org/obo/MONDO_0017945) (ABetaL34V amyloidosis), [MONDO:0011865](http://purl.obolibrary.org/obo/MONDO_0011865) (COL4A1-related familial vascular leukoencephalopathy), 

**Corr. equiv. classes:** [Orphanet:324713](http://www.orpha.net/ORDO/Orphanet_324713), [Orphanet:314572](http://www.orpha.net/ORDO/Orphanet_314572), [Orphanet:477759](http://www.orpha.net/ORDO/Orphanet_477759), [OMIM:600142](http://purl.obolibrary.org/obo/OMIM_600142), [OMIM:605714](http://purl.obolibrary.org/obo/OMIM_605714), [OMIM:180000](http://purl.obolibrary.org/obo/OMIM_180000), [Orphanet:324718](http://www.orpha.net/ORDO/Orphanet_324718), [Orphanet:247691](http://www.orpha.net/ORDO/Orphanet_247691), [OMIM:617341](http://purl.obolibrary.org/obo/OMIM_617341), [OMIM:117300](http://purl.obolibrary.org/obo/OMIM_117300), [Orphanet:36383](http://www.orpha.net/ORDO/Orphanet_36383), [Orphanet:482077](http://www.orpha.net/ORDO/Orphanet_482077), [OMIM:176500](http://purl.obolibrary.org/obo/OMIM_176500), [OMIM:612199](http://purl.obolibrary.org/obo/OMIM_612199), [Orphanet:482072](http://www.orpha.net/ORDO/Orphanet_482072), [OMIM:616779](http://purl.obolibrary.org/obo/OMIM_616779), [Orphanet:97346](http://www.orpha.net/ORDO/Orphanet_97346), [Orphanet:97345](http://www.orpha.net/ORDO/Orphanet_97345), [OMIM:607595](http://purl.obolibrary.org/obo/OMIM_607595), [Orphanet:136](http://www.orpha.net/ORDO/Orphanet_136), [Orphanet:481986](http://www.orpha.net/ORDO/Orphanet_481986), [OMIM:125310](http://purl.obolibrary.org/obo/OMIM_125310), [OMIM:105150](http://purl.obolibrary.org/obo/OMIM_105150), [Orphanet:324703](http://www.orpha.net/ORDO/Orphanet_324703), [Orphanet:199354](http://www.orpha.net/ORDO/Orphanet_199354), [Orphanet:477749](http://www.orpha.net/ORDO/Orphanet_477749), [Orphanet:324708](http://www.orpha.net/ORDO/Orphanet_324708), [Orphanet:85458](http://www.orpha.net/ORDO/Orphanet_85458), [Orphanet:477762](http://www.orpha.net/ORDO/Orphanet_477762), [OMIM:614483](http://purl.obolibrary.org/obo/OMIM_614483), [Orphanet:324723](http://www.orpha.net/ORDO/Orphanet_324723), [OMIM:192315](http://purl.obolibrary.org/obo/OMIM_192315), [Orphanet:100006](http://www.orpha.net/ORDO/Orphanet_100006), [Orphanet:477765](http://www.orpha.net/ORDO/Orphanet_477765), [Orphanet:100008](http://www.orpha.net/ORDO/Orphanet_100008), [Orphanet:313838](http://www.orpha.net/ORDO/Orphanet_313838), [Orphanet:73229](http://www.orpha.net/ORDO/Orphanet_73229), [OMIM:611773](http://purl.obolibrary.org/obo/OMIM_611773), [OMIM:175780](http://purl.obolibrary.org/obo/OMIM_175780), [Orphanet:75326](http://www.orpha.net/ORDO/Orphanet_75326), [Orphanet:99810](http://www.orpha.net/ORDO/Orphanet_99810), 

**Class expressions from DL-Learner:**

- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 41.85%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 41.85%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 41.85%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 39.97%
- [HP:0001297](http://purl.obolibrary.org/obo/HP_0001297) (Stroke) and (not ([HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology))) 39.97%
- [HP:0001297](http://purl.obolibrary.org/obo/HP_0001297) (Stroke) 33.53%
- [HP:0100659](http://purl.obolibrary.org/obo/HP_0100659) (Abnormality of the cerebral vasculature) 30.27%
- [HP:0011029](http://purl.obolibrary.org/obo/HP_0011029) (Internal hemorrhage) 29.60%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 29.22%
- Thing 29.21%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 29.21%
- [HP:0011028](http://purl.obolibrary.org/obo/HP_0011028) (Abnormality of blood circulation) 29.12%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 28.73%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 27.49%
- [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) 26.11%


